Supplement Library
FULL SUPPLEMENT: Scalp Health & the Role of the Scalp Barrier in Dandruff and Seborrheic Dermatitis
February 2025 | Volume 24 | Issue 2 | Department | 32710 | Copyright © February 2025
Research has shown that scalp and hair health are connected, but the link is not yet fully understood or characterized. Hair growth begins within the hair follicle, about 4 mm deep in the skin.1<...
Read MoreINDIVIDUAL ARTICLE: Insights on the Impact of Scalp Barrier Condition on Hair Health
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s3 | Copyright © February 2025
Scalp health is essential for healthy hair growth and may be affected by intrinsic or extrinsic factors. Reactive oxygens species are key contributors to aging and can have a detrimental impact o...
Read MoreINDIVIDUAL ARTICLE: Etiology, Treatment Challenges, and the Role of Scalp and Haircare in Managing Dandruff
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s8 | Copyright © February 2025
Dandruff and seborrheic dermatitis are associated with a disrupted scalp barrier that contributes to irritation, pruritus, and flaking of the scalp. The flaking and itch associated with dandruff ...
Read MoreFULL SUPPLEMENT: Masterful Topical JAK Inhibitor
February 2025 | Volume 24 | Issue 2 | Department | 49140 | Copyright © February 2025
Janus kinase (JAK) inhibitors, which have been used in a range of disease states from rheumatology to gastroenterology, have been finally adopted into dermatology. These agents are rapidly changing th...
Read MoreINDIVIDUAL ARTICLE: VEHICLES MATTER: DESIGNED FOR PURPOSE
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | 49141 | Copyright © February 2025
INDIVIDUAL ARTICLE: Appraisal of Ruxolitinib 1.5% Cream as a First-Line Topical Therapeutic Agent for Adolescents and Adults With Mild-to-Moderate Atopic Dermatitis
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s5 | Copyright © February 2025
Dermatology has entered the long-awaited paradigm shift from steroidal to non-steroidal therapeutics for the topical treatment of atopic dermatitis. Topical Janus kinase (JAK) inhibitors have gar...
Read MoreINDIVIDUAL ARTICLE: Ruxolitinib 1.5% Cream and the "Boxed Warning Paradox": Reappraisal of Safety Through the Lens of Pharmacokinetics
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s16 | Copyright © February 2025
Ruxolitinib 1.5% cream is the first-in-class topical Janus kinase (JAK) inhibitor approved for the treatment of atopic dermatitis in patients 12 years of age and older. The US Food and Drug Admin...
Read MoreFULL SUPPLEMENT: Obesity: The Impact on Biologic Selection
January 2025 | Volume 24 | Issue 1 | Department | 491710s1 | Copyright © January 2025
Obesity is a multifactorial disease with a rapidly increasing global prevalence. Its etiology is driven by a chronic imbalance between energy intake and energy expenditure. Excess energy is stored in ...
Read MoreINDIVIDUAL ARTICLE: Psoriasis Is a Systemic Disease
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491711s2 | Copyright © January 2025
INDIVIDUAL ARTICLE: Psoriasis and Obesity: Optimizing Pharmacologic Treatment and Lifestyle Interventions
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491722s4 | Copyright © January 2025
Obesity is a metabolic disease that is marked by excessive fat accumulation and is objectively defined as a body mass index (BMI) ≥30 kg/m2. Obesity is associated with several other...
Read MoreFULL SUPPLEMENT: Real-World Cases Using Topical Clascoterone Cream in Acne
January 2025 | Volume 24 | Issue 1 | Department | 733610s1 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lead to ...
Read MoreINDIVIDUAL ARTICLE: Real-World Cases of Clascoterone Topical Treatment for Acne and Related Disorders
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 73361s3 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lea...
Read MoreFULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (Uscom) Iv: A Multidisciplinary-Guided Algorithm For Preventing And Managing Cutaneous Targeted Therapy-Related Adverse Events In Cancer Patients
December 2024 | Volume 23 | Issue 12 | Department | 436613s16a | Copyright © December 2024
In 2023, an estimated 1,958,310 Americans were diagnosed with cancer.1 Although overall incidence continues to rise, ongoing advancements in anticancer therapy have improved survival. Some ...
Read MoreINDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events
December 2024 | Volume 23 | Issue 12 | Supplement Individual Articles | 436613s3 | Copyright © December 2024
Introduction: Targeted therapy has improved clinical outcomes for various types of cancer. However, their use is associated with dermatologic adverse events that impact quality o...
Read MoreFULL SUPPLEMENT: Topical Acne Treatment: What's Behind the Scenes in 2024
November 2024 | Volume 23 | Issue 11 | Department | 46941s1 | Copyright © November 2024
Optimal topical acne treatments should ideally target multiple pathways involved in acne development.2 Traditional treatments, though often effective, may come with limitations such as skin irri...
Read MoreINDIVIDUAL ARTICLE: VEHICLES ALWAYS MATTER
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 46941s3 | Copyright © November 2024
Over the past several years, the field of acne treatments, which had been relatively unchanged, has welcomed a variety of innovations. From new molecules and mechanisms of action to previously implaus...
Read MoreINDIVIDUAL ARTICLE: All for One and One for All: The Three Musketeers of Topical Acne Treatment and the Current Landscape
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 46942s4 | Copyright © November 2024
What is the ideal topical acne therapeutic? Topical therapeutics for acne vulgaris have advanced considerably over the last decade. Novel vehicular technologies have increased transdermal penetra...
Read MoreFULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Department | 43661s1 | Copyright © November 2024
By 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021. As the population and their s...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections
November 2024 | Volume 23 | Issue 11 | Supplement Individual Articles | 43661s3 | Copyright © November 2024
We evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide diaminobutyroyl, 5% polyhydroxy acids (PHA), 5% niacinamide, and 1% laminaria ...
Read MoreFULL SUPPLEMENT: Targeting Acne Pathogenesis with Topical Therapies
October 2024 | Volume 23 | Issue 10 | Department | 54120s1 | Copyright © October 2024
We, as dermatologists, are exceedingly lucky. We can watch our patients improve before our eyes. In clinical practice, we don't often track a quantitative metric to gauge success but rather meas...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
